UCB, a global biopharmaceutical company, today announced the start of BE BOLD, a head-to-head Phase 3b study, comparing BIMZELX® (bimekizumab-bkzx), an interleukin (IL)-17A and IL-17F inhibitor, with ...

Cantu, who is based full-time in Boston, is a co-founder of the Concussion Legacy Foundation (CLF) as well as Boston University’s CTE Center. Back in 2018, CLF began urging that football under ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline results from the Phase ...

Sometimes diet and exercise are not enough to help the 100 million Americans with obesity lose weight and prevent health ...

ZORYVE demonstrated consistent efficacy in disease clearance and reduction in itch for individuals with atopic dermatitis (AD) regardless of ...

This year, chikungunya patients in Pune are experiencing a range of atypical symptoms, including mild fevers, persistent joint pain, and chickenpox-like rashes. Medical professionals are observing a ...

There’s no feeling quite as vindicating as finding your “holy grail” beauty or skin care product. Finally, you can take the ...

Following our previous report on an outbreak of gastroenteritis in Grand Turk, the Ministry of Health and Human Services can ...

When researchers discovered enough proof that a medication used to treat bone marrow cancer and Kaposi sarcoma is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare ...

Read full article: Teen and adult dead, 5 others hospitalized after home collapses on family in Brazoria County Read full ...